|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Gross written premiums | |||||
| Ceded written premiums | |||||
| Net written premiums | |||||
| Change in unearned premiums | |||||
| Net earned premiums | |||||
| Insurance Fee Income | |||||
| Net investment income | |||||
| Change in the fair value of equity securities | |||||
| Net realized investment gains | |||||
| Change in allowance for credit losses on investments | |||||
| Other income | |||||
| Total revenues | |||||
| Expenses: | |||||
| Losses and loss adjustment expenses | |||||
| Underwriting, acquisition and insurance expenses | |||||
| Interest expense | |||||
| Other expenses | |||||
| Total expenses | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Other comprehensive income (loss): | |||||
| Change in unrealized gains (losses) on available-for-sale investments, net of taxes | |||||
| Total comprehensive income | |||||
| Earnings per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average common shares outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...
